Romain Loyon

756 total citations
23 papers, 443 citations indexed

About

Romain Loyon is a scholar working on Oncology, Immunology and Molecular Biology. According to data from OpenAlex, Romain Loyon has authored 23 papers receiving a total of 443 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Oncology, 15 papers in Immunology and 4 papers in Molecular Biology. Recurrent topics in Romain Loyon's work include Immune Cell Function and Interaction (10 papers), Cancer Immunotherapy and Biomarkers (9 papers) and CAR-T cell therapy research (7 papers). Romain Loyon is often cited by papers focused on Immune Cell Function and Interaction (10 papers), Cancer Immunotherapy and Biomarkers (9 papers) and CAR-T cell therapy research (7 papers). Romain Loyon collaborates with scholars based in France, Switzerland and United States. Romain Loyon's co-authors include Christophe Borg, Olivier Adotévi, Yann Godet, Marie Kroemer, Jeanne Galaine, Marine Jary, Paul Peixoto, Pedro Romero, Éric Hervouet and Camilla Jandus and has published in prestigious journals such as Nature Communications, The Journal of Immunology and Cancer Research.

In The Last Decade

Romain Loyon

22 papers receiving 442 citations

Peers

Countries citing papers authored by Romain Loyon

Since Specialization

Citations

This map shows the geographic impact of Romain Loyon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Romain Loyon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Romain Loyon more than expected).

Fields of papers citing papers by Romain Loyon

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Romain Loyon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Romain Loyon. The network helps show where Romain Loyon may publish in the future.

Co-authorship network of co-authors of Romain Loyon

This figure shows the co-authorship network connecting the top 25 collaborators of Romain Loyon. A scholar is included among the top collaborators of Romain Loyon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Romain Loyon. Romain Loyon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Clinical and biological determinants of multimodal metronomic chemotherapy efficacy in chemo‐refractory gastrointestinal cancers 2025 ·International Journal of Cancer ·Laurie Spehner, Adeline Bouard, (unknown), Marie Kroemer, Stéfano Kim, Thierry Nguyen, (unknown), Francine Fein, (unknown), Romain Loyon, Christophe Borg, Angélique Vienot	0
2	Exploring the role of ESR1 mutations in metastatic hormone receptor-positive breast cancer T cell immune surveillance disruption 2025 ·Breast Cancer Research ·(unknown), Laurie Spehner, Fabrice André, (unknown), (unknown), (unknown), Elsa Curtit, (unknown), Erion Dobi, Sylvain Ladoire, Romain Boidot, Romain Loyon, Valentin Dérangère, François‐Clément Bidard, Christophe Borg, Laura Mansi, Marie Kroemer	2
3	Characterization of the aryl hydrocarbon receptor as a potential candidate to improve cancer T cell therapies 2025 ·Cancer Immunology Immunotherapy ·(unknown), (unknown), Barbara Dehecq, (unknown), (unknown), (unknown), Francine Garnache‐Ottou, Olivier Adotévi, Romain Loyon, Yann Godet	1
4	Liver metastases of colorectal cancer contain different subsets of tissue-resident memory CD8 T cells correlated with a distinct risk of relapse following surgery 2025 ·OncoImmunology ·(unknown), Alexandre Doussot, Marie Kroemer, Eve Laloy, Jean‐René Pallandre, (unknown), Laurie Spehner, (unknown), Adeline Bouard, Virginie Mougey, (unknown), Angélique Vienot, (unknown), Zaher Lakkis, Franck Monnien, Romain Loyon, Christophe Borg	3
5	CRISPR-Cas gene knockouts to optimize engineered T cells for cancer immunotherapy 2024 ·Cancer Gene Therapy ·(unknown), Jeanne Galaine, Romain Loyon, Yann Godet	11
6	SALL4 ‐related gene signature defines a specific stromal subset of pancreatic ductal adenocarcinoma with poor prognostic features 2023 ·Molecular Oncology ·Angélique Vienot, Franck Monnien, Caroline Truntzer, Virginie Mougey, Adeline Bouard, Jean‐René Pallandre, (unknown), Romain Loyon, (unknown), Gerlinde Avérous, François Ghiringhelli, Frédéric Bibeau, Paul Peixoto, Christophe Borg	5
7	Microfluidic device combining hydrodynamic and dielectrophoretic trapping for the controlled contact between single micro-sized objects and application to adhesion assays 2023 ·Lab on a Chip ·(unknown), (unknown), Romain Loyon, Aude Bolopion, Laurie Spehner, Michaël Gauthier, Christophe Borg, Arnaud Bertsch, Philippe Renaud	6
8	Harnessing Antitumor CD4+ T Cells for Cancer Immunotherapy 2022 ·Cancers ·(unknown), Yann Godet, (unknown), Christophe Borg, Olivier Adotévi, Romain Loyon	41
9	Tissue-resident memory T cells in gastrointestinal cancer immunology and immunotherapy: ready for prime time? 2022 ·Journal for ImmunoTherapy of Cancer ·(unknown), (unknown), Marie Kroemer, (unknown), Angélique Vienot, Bruno Heyd, Romain Loyon, Alexandre Doussot, Christophe Borg	13
10	PPARɣ drives IL-33-dependent ILC2 pro-tumoral functions 2021 ·Nature Communications ·Giuseppe Ercolano, Alejandra Gomez‐Cadena, (unknown), (unknown), Mario Kreutzfeldt, Tania Wyss, Liliane Michalik, Romain Loyon, Angela Ianaro, Ping‐Chih Ho, Christophe Borg, Manfred Köpf, Doron Merkler, Philippe Krebs, Pedro Romero, Sara Trabanelli, Camilla Jandus	62
11	Epigenetic Reprogramming of CD4+ Helper T Cells as a Strategy to Improve Anticancer Immunotherapy 2021 ·Frontiers in Immunology ·(unknown), Marie Kroemer, Christophe Borg, Paul Peixoto, Éric Hervouet, Romain Loyon, Olivier Adotévi	28
12	Homeostatic cytokines tune naivety and stemness of cord blood-derived transgenic T cells 2021 ·Cancer Gene Therapy ·(unknown), (unknown), Romain Loyon, Olivier Adotévi, Christophe Borg, Jeanne Galaine, Yann Godet	4
13	Investigation of the prognostic value of CD4 T cell subsets expanded from tumor-infiltrating lymphocytes of colorectal cancer liver metastases 2020 ·Journal for ImmunoTherapy of Cancer ·Marie Kroemer, Célia Turco, Laurie Spehner, (unknown), (unknown), Adeline Bouard, (unknown), Marina Deschamps, Yann Godet, Olivier Adotévi, Samuel Limat, Bruno Heyd, Marine Jary, Romain Loyon, Christophe Borg	31
14	Molecular description of ANGPT2 associated colorectal carcinoma 2020 ·International Journal of Cancer ·Marine Jary, (unknown), Angélique Vienot, (unknown), Romain Loyon, (unknown), Adeline Bouard, (unknown), (unknown), Stéfano Kim, (unknown), (unknown), Olivier Adotévi, Olivier Bouché, Thierry Lecomte, Christophe Borg, Jean Paul Feugeas	22
15	The Fate of Th17 Cells is Shaped by Epigenetic Modifications and Remodeled by the Tumor Microenvironment 2020 ·International Journal of Molecular Sciences ·(unknown), Marie Kroemer, Romain Loyon, Delphine Binda, Christophe Borg, Michaël Boyer‐Guittaut, Éric Hervouet, Paul Peixoto	30
16	CD4 T cells target colorectal cancer antigens upregulated by oxaliplatin 2019 ·International Journal of Cancer ·Jeanne Galaine, Célia Turco, Charline Vauchy, Bernard Royer, (unknown), (unknown), Romain Loyon, (unknown), Romain Boidot, Caroline Laheurte, Zaher Lakkis, Marine Jary, Olivier Adotévi, Christophe Borg, Yann Godet	36
17	Peripheral Innate Lymphoid Cells Are Increased in First Line Metastatic Colorectal Carcinoma Patients: A Negative Correlation With Th1 Immune Responses 2019 ·Frontiers in Immunology ·Romain Loyon, Marine Jary, Bérengère Salomé, Alejandra Gomez‐Cadena, Jeanne Galaine, Marie Kroemer, Pedro Romero, Sara Trabanelli, Olivier Adotévi, Christophe Borg, Camilla Jandus	37
18	Induction of Paracrine Signaling in Metastatic Melanoma Cells by PPARγ Agonist Rosiglitazone Activates Stromal Cells and Enhances Tumor Growth 2018 ·Cancer Research ·Christine Pich-Bavastro, Patrick Meylan, Béatris Mastelic-Gavillet, (unknown), Romain Loyon, (unknown), (unknown), Catherine Moret, Christine Goepfert, Jürg Hafner, Mitchell P. Levesque, Pedro Romero, Camilla Jandus, Liliane Michalik	20
19	Circulating NKp46⁺Natural Killer cells have a potential regulatory property and predict distinct survival in Non-Small Cell Lung Cancer 2018 ·OncoImmunology ·Émilie Picard, Yann Godet, Caroline Laheurte, Magalie Dosset, Jeanne Galaine, (unknown), Romain Loyon, Laura Boullerot, Elodie Lauret Marie Joseph, Laurie Spehner, Marion Jacquin, Guillaume Eberst, Béatrice Gaugler, Françoise Le Pimpec‐Barthes, Elizabeth Fabre, Virginie Westeel, Anne Caignard, Christophe Borg, Olivier Adotévi	29
20	IL-21–Induced MHC Class II+ NK Cells Promote the Expansion of Human Uncommitted CD4+ Central Memory T Cells in a Macrophage Migration Inhibitory Factor–Dependent Manner 2016 ·The Journal of Immunology ·Romain Loyon, Émilie Picard, Olivier Mauvais, (unknown), Virginie Mougey, Jean‐René Pallandre, Jeanne Galaine, (unknown), (unknown), Nathalie Chaput, John Wijdenes, Olivier Adotévi, Christophe Ferrand, Pedro Romero, Yann Godet, Christophe Borg	24

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact